Task: Answer the multiple-choice question.
Question: Which drug exhibits a -19.161% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. CCOCCn1ccc2c(OCC(=O)NCCc3ccc(OC)c(OC)c3)cccc2c1=O
b. Cc1cccc(OCc2nc(-c3nonc3N)no2)c1C
c. O=C(CCc1nnc(CCc2ccccc2)o1)NC(c1cccnc1)C(F)(F)F
d. O=C1NC[C@@H](Cc2cccc3ccccc23)N(CCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C1=O
e. CCOc1cc(/C=N/NC(N)=O)cc(Br)c1OCc1ccccc1
Answer: a. CCOCCn1ccc2c(OCC(=O)NCCc3ccc(OC)c(OC)c3)cccc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOCCn1ccc2c(OCC(=O)NCCc3ccc(OC)c(OC)c3)cccc2c1=O
CCOCCn1ccc2c(OCC(=O)NCCc3ccc(OC)c(OC)c3)cccc2c1=O
N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[2-(2-ethoxyethyl)-1-oxoisoquinolin-5-yl]oxyacetamide